1
Total investments
1
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2018
restor3d enables surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. Leveraging expertise and experience in 3D printing of key biomedical materials spanning a wide range of properties, restor3d seeks to improve medical device solutions.
Experience · 4 entries
All (4)
Investments (1)
2021
Principal, Head of healthcare
2021
Atomic is the venture studio that pioneered the model of starting companies by pairing founders with the best ideas, teams, and resources. When entrepreneurs team up with Atomic, they join a group of experienced founders and a ready-made team of experts who have successfully built many companies, generating billions of dollars in value. Our fourth fund of $320 million is used exclusively to fund companies started at Atomic.
2018
Principal
2018
Archon.Capital is a family-run investment firm with a focus on early-stage investments into promising founders.
Investor
2018
restor3d enables surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. Leveraging expertise and experience in 3D printing of key biomedical materials spanning a wide range of properties, restor3d seeks to improve medical device solutions.
2013
Summer Associate
2013
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.
Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do.
Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
Similar investors
Co-investors and Manufacturing early-stage investors in United States
Investor lists
Lists that match Phillip's portfolio
- Manufacturing early-stage investors in United States2,280 investors
- Early-stage startup investors in United States3,677 investors






